Scientific evidence classification · Phase 6A preserved + Phase 6B additions
PWWP Compounds
& Bioactivity
Explore experimentally studied preparations separately from deposited research ligands, buffers, ions and unresolved chemical evidence. Every role is source- and target-context specific.
Combined Phase 6A + Phase 6B denominators. These groups overlap; the 109 structurally source-tagged research ligands are unchanged. Deposited components and reagents are not automatically biochemical binders.
Evidence classification · exact source records
31 matching profiles
34 matching assay / association observations. Counts here are profiles, not unique assay events or deposited ligand instances; views overlap.
Measurements remain attached to the reported preparation.
compound 1 (de Freitas 2021)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 11 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 12 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 13 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 5 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 6 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
compound 7 (Collie 2025)
Measurements remain attached to the reported preparation.
HS13
Source verification is pending.
Unresolved preparation · individual modeled components do not inherit its potency.
MR837 (3f)
MRT866
UNC7096
UNC7145
No source-curated measured assay in this context. Structural evidence is shown separately.
UNC8153
Measurements remain attached to the reported preparation.
UNC8269
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
UNC8325
Unresolved preparation · individual modeled components do not inherit its potency.
UNC8732
Measurements remain attached to the reported preparation.
UNC8884
No source-curated measured assay in this context. Structural evidence is shown separately.
Unresolved preparation · individual modeled components do not inherit its potency.
(2S)-1-[4-[[(3R)-1,1-bis(oxidanylidene)thiolan-3-yl]methyl-methyl-amino]-6-methyl-pyrimidin-2-yl]-N-methyl-pyrrolidine-2-carboxamide
No source-curated measured assay in this context. Structural evidence is shown separately.
(2S)-1-[4-[[(3S)-1,1-bis(oxidanylidene)thiolan-3-yl]methyl-methyl-amino]-6-methyl-pyrimidin-2-yl]-N-methyl-pyrrolidine-2-carboxamide
No source-curated measured assay in this context. Structural evidence is shown separately.
(6R)-6-(3,5-dichlorophenyl)morpholin-3-one
No source-curated measured assay in this context. Structural evidence is shown separately.
(Z)-N-methyl-3-sulfanyl-prop-2-enamide
No source-curated measured assay in this context. Structural evidence is shown separately.
1-(5-{9-[(4-{2-[(2S,3R)-2-(3,5-dichloro-4-fluorophenyl)-5-oxomorpholin-3-yl]ethyl}piperazin-1-yl)methyl]-3-azaspiro[5.5]undecane-3-carbonyl}-2-methylphenyl)-1,3-diazinane-2,4-dione
No source-curated measured assay in this context. Structural evidence is shown separately.
4-[5-[4-(aminomethyl)-2,6-dimethoxy-phenyl]-3-methyl-imidazol-4-yl]benzenecarbonitrile
No source-curated measured assay in this context. Structural evidence is shown separately.
Source SMILES and full InChIKey require reconciliation.
4-[[cyclopropyl-[(~{Z})-2-methyl-4-(5-oxidanylidene-2~{H}-1,4-oxazin-3-yl)but-3-enoyl]amino]methyl]-~{N}-[3-[2-[[4-(hydroxymethyl)phenyl]carbonyl-methyl-amino]ethyl]phenyl]benzamide
Source verification is pending.
4-methyl-3-[1-methyl-5-(3-oxidanylidene-4~{H}-1,4-benzoxazin-7-yl)imidazol-4-yl]-~{N}-phenyl-benzamide
No source-curated measured assay in this context. Structural evidence is shown separately.
7-[3-methyl-5-[2-methyl-5-[(pyridin-3-ylamino)methyl]phenyl]imidazol-4-yl]-4~{H}-1,4-benzoxazin-3-one
No source-curated measured assay in this context. Structural evidence is shown separately.
7-[5-methyl-3-[2-methyl-5-(piperidin-1-ylmethyl)phenyl]-1,2-oxazol-4-yl]-4~{H}-1,4-benzoxazin-3-one
No source-curated measured assay in this context. Structural evidence is shown separately.
N-(2-methoxyphenyl)-2-selanyl-benzamide
No source-curated measured assay in this context. Structural evidence is shown separately.
~{N}-(4-aminophenyl)-2-selanyl-benzamide
No source-curated measured assay in this context. Structural evidence is shown separately.
~{N}-cyclopropyl-~{N}-[[4-[[2-(6-oxidanylhexanoyl)-1~{H}-isoquinolin-6-yl]carbamoyl]phenyl]methyl]-3-oxidanylidene-4~{H}-1,4-benzoxazine-7-carboxamide
No source-curated measured assay in this context. Structural evidence is shown separately.